Call for paper 〔OPEN〕

My submissions

Registration 〔OPEN〕

My tickets

〔CLOSED〕
Introduction

A recent report in Nature News & Comment stated that China is positioning itself as a world leader in primate research (Nature 2016; 532: 300-302). Most probably China will become the place where all therapeutic strategies have to be validated despite challenges. The rapid developed gene-editing methods such as CRISPR and TALENT has been successfully used for produce genomic edited nonhuman primate models for human diseases, and the latest founding of the DNA-guided endonuclease named NgAgo seems promise a high efficiency in genome editing(Nature Biotechnology 2016 May 2. doi: 10.1038/nbt.3547). Recent successes in generation of nonhuman primate chimeric fetuses using embryonic stem cells (Cell Stem Cell 2015;17:116-24) and genetic engineered cynomolgus models exhibiting autism-like behaviours (Nature 2016;530:98-102)furtherly promoted the development of biomedical research in primates. Substantial increasing requirement in nonhuman primate disease models and stem cell therapies for human disease and health can be anticipated in the near future. Yunnan key laboratory of primate biomedical research (LPBR) has been promoting the development of biomedical research in primates. In this year, the conference will focus on the frontiers of translational research in primate stem cells, gene editing and gene therapy. We hope that this will make even greater progress and stimulate more discussions and research on primate research.

Call for paper

Important date

2016-07-10
Abstract submission deadline

Submission Topics

Genome Editing and Therapy

New methods such as CRISPR, TALEN and NgAgo permit rapid and efficient genomic modifications, and are increasingly used in the laboratory and are potential tools for gene therapy in humans. Custom monkeys with specific gene modified have become a more efficient experimental tool due to the new reproductive technologies and efficient genetic-engineering techniques. 

Stem Cell & Translational Medicine

Progress on stem cell research translation promise great prospects for treatment of degenerative, chronic and/or fatal diseases and injuries in human clinical trial. The nonhuman primate could contribute to initial experimental success and protocol development, with the potential for animal studies involving safety and efficacy evaluation. Establishing the medical potential of stem cell-derived phenotypes involves evaluating safety from the host's perspective and efficacy of the graft post-transplantation. A role for animal experimentation and especially for NHPs in neurodegenerative conditions seems obvious. It is clear that NHP research activities are appropriate and desirable in translational research when a NHP model is necessitated by ethical concerns and the requirement for primate testing.

Nonhuman Primate Models for Human Diseases

The selection of the laboratory species is one of the most important decisions to be made in biomedical research. Nonhuman primates have been considered as the best preclinical models that will more closely reflect human physiological characteristics and behavior but will be less susceptible to some diseases than other animals. Therefore, the use of NHP remains unavoidable in several essential research areas, such as Type 2 Diabetes and Lipid Metabolism, AIDS, Drug Abuse / Dependence Studies and Neuro-Degenerative Diseases. In this topic, we will focus on employment and potential applications of nonhuman primate models in biomedical researc

Submit Comment
Verify Code Change Another
All Comments
Important Date
  • Conference Date

    Aug 21

    2016

    to

    Aug 23

    2016

  • Jul 10 2016

    Abstract Submission Deadline

  • Aug 23 2016

    Registration deadline

Sponsored By
昆明理工大学灵长类转化医学研究院
Supported By
昆明理工大学灵长类转化医学研究院
Contact Information